LyoTechnica To Provide Parenteral Development Services

LyoTechnica, LLC has launched as a contract drug development services provider for injectable pharmaceuticals. The Carlsbad-CA company and its affiliates will provide lyophilization and liquid dosage form development, as well as commercial scale manufacturing of parenteral drugs. LyoTechnica also offers analytical and formulation development, manufacturing of sterile stability batches and stability testing services.

The company offers services for liquid or lyophilized aseptic dosage forms, including high potency and cytotoxic products, as well as small molecule or biopharmaceutical products. LyoTechnica also provides regulatory support services, including Electronic Common Technical Development (eCTD) submission services.

“LyoTechnica was formed to help speed the drug development process for injectable drugs,” said Glenn F. Wickes, Jr., president and chief executive officer. “We work with pharmaceutical companies with limited resources as well as larger firms needing additional resources applied quickly to a project. Our framework allows for cost-effective and efficient development.”